Quality assessment tools add value.

L Paul

Home/Archive/PubMed

PubMed · 10162486

Quality assessment tools add value.

L Paul

View original source ↗Export metadata ↓

Abstract

The rapid evolution of the health care marketplace can be expected to continue as we move closer to the 21st Century. Externally-imposed pressures for cost reduction will increasingly be accompanied by pressure within health care organizations as risk-sharing reimbursement arrangements become more commonplace. Competitive advantage will be available to those organizations that can demonstrate objective value as defined by the cost-quality equation. The tools an organization chooses to perform quality assessment will be an important factor in its ability to demonstrate such value. Traditional quality assurance will in all likelihood continue, but the extent to which quality improvement activities are adopted by the culture of an organization may determine its ability to provide objective evidence of better health status outcomes.

Explore related subjects

Cost Control Economic Competition Health Services Research Hospital Administration Joint Commission on Accreditation of Healthcare Organizations Models, Organizational Outcome and Process Assessment, Health Care Quality Assurance, Health Care Total Quality Management Utilization Review Journal Article

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

L Paul. 1996. Quality assessment tools add value.. https://pubmed.ncbi.nlm.nih.gov/10162486/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2001

Pharmaceutical price controls and patient welfare.

Price controls could have a substantial negative effect on pharmaceutical research and development. Extensive research is required before the development costs of a new drug or its benefits are known; most new drug development projects fail, sometimes after substantial financial and time costs. These conditions pose intractable practical problems for the operation of price controls, which cannot rest on objective, predictable standards such as the benefits or costs of individual drugs. In the absence of objective standards, pressure from health care providers and others would create powerful incentives for price regulators to decrease drug prices toward marginal costs of production and distribution, well below levels sufficient to reward innovative research. This downwardly biased price-setting mechanism would apply with particular force to the few successful projects that yield innovative drugs, whose prices would not be set by regulatory authorities until after research expenditures have been incurred and the new drugs are ready to enter the market. Manufacturers will expect price controls to reduce the potential payoffs from breakthrough drugs. This expectation would substantially reduce the incentives to pursue innovative research, as is evident in advanced economies in which price controls are now in force. Once established, price controls for pharmaceuticals, like those for medical services in the Medicare system, would also tend toward complexity and entrenchment of vested interests and could easily become permanent regardless of the harm they cause to patients.

Cost Control↗

PubMed2001

Implementing national guidelines at local level.

Explore the source record for details and available documents.

Cost Control↗

PubMed2001

[Marketing potential of the medical practice].

Since the 1970s, market forces and cost containment have stimulated a range of economic changes for health care providers. There is increasing pressure for medical practices and other health care organizations to provide simultaneously excellent clinical, financial and satisfaction outcomes. To fulfill these expectations, two central aspects have been identified: customer focus and involvement of all members of a medical organization. Therefore, it is essential to understand the patient's perspective and, where necessary, increase quality of care from the customer's viewpoint. Generally, quality as defined by the customer and by the medical professionals differ substantially. In this article, we present a check-list to evaluate the essential aspects of a medical practice from a patient's view which, in turn, will help to determine which actions have to be taken. Some of the aspects covered by the checklist include satisfaction with care delivered, service performed, warmth of the employees, office's facilities, and physician's behavior.

Cost Control↗